Clinical Trials
5
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)A Study of OBP-301 With Radiation Therapy in Patients With Esophageal Cancer
Phase 1
- Conditions
- Esophageal Cancer
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Oncolys BioPharma Inc
- Target Recruit Count
- 12
- Registration Number
- NCT03213054
- Locations
- 🇯🇵
Research site, Kita, Okayama, Japan
A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
- First Posted Date
- 2015-04-10
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Oncolys BioPharma Inc
- Target Recruit Count
- 17
- Registration Number
- NCT02414516
- Locations
- 🇺🇸
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Phase 1
- Conditions
- Carcinoma, Hepatocellular
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- Oncolys BioPharma Inc
- Target Recruit Count
- 18
- Registration Number
- NCT02293850
- Locations
- 🇰🇷
Pusan National University Hospital, Busan, Korea, Republic of
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
News
No news found